In-house Produced PMMA- Versus PEEK-cages (Palcage)
Primary Purpose
Cervical Disc Degeneration, Cervical Stenosis
Status
Completed
Phase
Phase 1
Locations
Study Type
Interventional
Intervention
Implantation of a PEEK-cage
PMMA-cage
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Disc Degeneration
Eligibility Criteria
Inclusion Criteria:
- virgin spines
- no emergency operation
- age above 18
- sufficient knowledge of the German language
- indication for anterior cervical discectomy and fusion
- absence of concomitant spinal disease
Exclusion Criteria:
- prior cervical surgery
- indications other than ACDF
- concomitant neoplastic, metabolic, severe general or infectious disease
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
PEEK-cage
PMMA-cage
Arm Description
Patients will receive a PEEK-cage
Outcomes
Primary Outcome Measures
Clinical outcome (NDI)
NDI (Neck disability index) will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage).
Secondary Outcome Measures
Clinical outcome (VAS-neck), Subsidence
VAS-neck will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage).
Cage Subsidence will be measured using lateral radiographs prior to surgery and 12 months after surgery. Due to an improved cage design, significantly less subsidence is proposed for the experimental implant (PMMA-cage).
Full Information
NCT ID
NCT01607775
First Posted
May 22, 2012
Last Updated
June 4, 2012
Sponsor
Universitätsmedizin Mannheim
1. Study Identification
Unique Protocol Identification Number
NCT01607775
Brief Title
In-house Produced PMMA- Versus PEEK-cages
Acronym
Palcage
Official Title
Clinical Characterization of In-house Produced PMMA-cages in Patients With Cervical Pathology
Study Type
Interventional
2. Study Status
Record Verification Date
June 2012
Overall Recruitment Status
Completed
Study Start Date
February 2009 (undefined)
Primary Completion Date
February 2012 (Actual)
Study Completion Date
February 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitätsmedizin Mannheim
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Subsidence of cervical cages is a common problem. For the study, a new polyacrylmethacrylate cage was designed and prospectively implanted in patients with a mono- or bilevel cervical pathology. As control, a commercially available PEEK-cage was used, patients were randomized using minimization randomization, controlling for age and bone mineral densitiy. The investigators hypothesize that the newly developed cage has similar clinical and radiological qualities compared to the PEEK-cage, but at a much more favourable cost-performance ratio.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Disc Degeneration, Cervical Stenosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
88 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PEEK-cage
Arm Type
Active Comparator
Arm Description
Patients will receive a PEEK-cage
Arm Title
PMMA-cage
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Implantation of a PEEK-cage
Intervention Description
A commercially avaliable cuboid cervical cage will be implantet
Intervention Type
Device
Intervention Name(s)
PMMA-cage
Intervention Description
The in-house produced cervical cage will be implanted
Primary Outcome Measure Information:
Title
Clinical outcome (NDI)
Description
NDI (Neck disability index) will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage).
Time Frame
12 months postoperative
Secondary Outcome Measure Information:
Title
Clinical outcome (VAS-neck), Subsidence
Description
VAS-neck will be measured prior to surgery and 12 months after surgery. A difference of 20% between both groups is considered to be clinically significant, which is proposed for the experimental implant (PMMA-cage).
Cage Subsidence will be measured using lateral radiographs prior to surgery and 12 months after surgery. Due to an improved cage design, significantly less subsidence is proposed for the experimental implant (PMMA-cage).
Time Frame
12 months postoperative
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
virgin spines
no emergency operation
age above 18
sufficient knowledge of the German language
indication for anterior cervical discectomy and fusion
absence of concomitant spinal disease
Exclusion Criteria:
prior cervical surgery
indications other than ACDF
concomitant neoplastic, metabolic, severe general or infectious disease
12. IPD Sharing Statement
Learn more about this trial
In-house Produced PMMA- Versus PEEK-cages
We'll reach out to this number within 24 hrs